Mizuho Securities Reiterates Buy Following Ironwood Pharma's (IRWD) Strong 4Q Results
Tweet Send to a Friend
Mizuho Securities reiterated a Buy rating and $15.00 price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) following the company's 4Q earnings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
